Announcement of the Conflict and Coordination of China's Drug Patent Compulsory Licensing System under the Health Crisis
- DOI
- 10.2991/978-2-494069-89-3_120How to use a DOI?
- Keywords
- Public Health; compulsory licensing; pharmaceutical patents; public health prevention and control; pharmaceutical accessibility
- Abstract
Public health is currently a significant issue in growing China and even on a worldwide scale. SARS, H1N1, H7N9 avian influenza, and the recent outbreak of coronary pneumonia are just a few of the significant health and safety disasters that have significantly jeopardized public health in our nation in the first two decades of the twenty-first century. One of the most challenging concerns affecting Chinese people's ability to support themselves has been the public health problem.
This paper examines the current state of the difficulties in implementing the compulsory licensing system for pharmaceuticals in China, compares the provisions and implementation of the system in developed and developing nations, such as India and Brazil, and reviews pertinent literature to highlight the deficiencies of the compulsory licensing system for pharmaceuticals in China and offer suggestions for improvement.
- Copyright
- © 2022 The Author(s)
- Open Access
- Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Cite this article
TY - CONF AU - Yunan Yang PY - 2022 DA - 2022/12/30 TI - Announcement of the Conflict and Coordination of China's Drug Patent Compulsory Licensing System under the Health Crisis BT - Proceedings of the 2022 5th International Conference on Humanities Education and Social Sciences (ICHESS 2022) PB - Atlantis Press SP - 1036 EP - 1041 SN - 2352-5398 UR - https://doi.org/10.2991/978-2-494069-89-3_120 DO - 10.2991/978-2-494069-89-3_120 ID - Yang2022 ER -